openPR Logo
Press release

Biopsy Devices Pipeline Insight and Competitive Landscape, 2022 | DelveInsight

06-02-2022 12:09 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Biopsy Devices Pipeline

Biopsy Devices Pipeline

DelveInsight's "Biopsy Devices - Pipeline Insight and Competitive Landscape, 2022," report provides comprehensive insights about 20+ companies and 23+ pipeline devices in the biopsy devices pipeline landscape. Significant increase in the incidence of cancer, such as breast, prostate, and lung, and rapid technological advancements such as 3D optical biopsies, MRI-targeted biopsies, and Ultrasound-guided biopsies fuel the adoption of biopsy devices.

Moreover, a rise in awareness of the diagnosis of chronic diseases fosters the demand for integrated biopsy technologies such as stereo-tactic-guided biopsy.

This report provides a detailed study of the emerging biopsy devices along with the competitive landscape to help better understand the market.

Request for a Free Sample Report @ https://www.delveinsight.com/sample-request/biopsy-devices-pipeline-insight-and-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Geography Covered: Global coverage

Biopsy Devices Overview

Biopsy devices are instruments that aid in the removal of tissue samples from the body. These samples are collected in order to examine it more closely.

When a Biopsy is needed?

1. A mammogram shows a lump or mass, indicating the possibility of breast cancer
2. A mole on the skin has changed shape recently and melanoma is possible
3. A person has chronic hepatitis and it's important to know if cirrhosis is present

Visit to know more about the Biopsy Devices, treatment algorithms in different geographies, and patient journey contact @ https://www.delveinsight.com/report-store/biopsy-devices-pipeline-insight-and-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Biopsy Devices Competitive Assessment

This segment of the biopsy devices pipeline report encloses its detailed analysis of various pipeline devices which include product description, licensing and collaboration details, and other developmental activities including the latest news and press releases. The report also provides a list of major players involved in the pipeline product development.

Product Type

The biopsy devices pipeline report is segmented based on product types such as core biopsy devices, aspiration biopsy needles, and vacuum-assisted biopsy devices.

Product Technique

Based on the technology biopsy devices are of various types:

1. Ultrasound-guided Biopsy
2. Stereotactic-guided Biopsy
3. MRI-guided Biopsy
The biopsy device pipeline assessment covers the entire types of these techniques.

Product Application

The biopsy devices are used in breast biopsy, lung biopsy, colorectal biopsy and prostate biopsy.

Request for a sample report to understand more about the Biopsy Devices pipeline development activities at: https://www.delveinsight.com/report-store/biopsy-devices-pipeline-insight-and-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Major Players in Biopsy Devices

There are approx. 20+ key companies which are developing the products for biopsy devices.

Learn more about the key companies at:
https://www.delveinsight.com/report-store/biopsy-devices-pipeline-insight-and-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

3D Biopsy Device: 3DBiopsy, Inc.

3D Biopsy is developing a new variable biopsy device, capable of taking a prostate specimen up to 2 to 5 cm in length, along with a biopsy needle that retrieves over 90% of the tissue sampled. The current biopsy devices take short (average 12 mm) fragmented specimens which miss cancers in 30% and mischaracterize the tumor aggressiveness in up to 50%. Patients undergoing MRI targeted fusion biopsy also require additional sampling due to the inadequacy of the shorter specimens. The Company's device will sample both peripheral and anterior zones and is capable of completely encompassing regions of interest when MRI fusion is performed.

The OsteoAccess System: ActuatedMedical

Actuated Medical developed the OsteoAccess System to assist clinicians in bone marrow biopsy and aspiration procedures. The System uses controlled, micron-scale needle vibration to reduce the penetration force enabling easier cortical bone access.

Biopsy Devices Report Highlights

1. Extensive coverage of the biopsy devices under development
2. The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
3. The report reviews the major players involved in the development of biopsy devices and list all their pipeline projects
4. The coverage of pipeline products is based on various stages of development ranging from Early Development to Approved / Issued stage
5. The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment/industry
6. The report consists of an depth analysis of pipeline products based on various parameters

Request a sample and discover more about the report offerings at: https://www.delveinsight.com/sample-request/biopsy-devices-pipeline-insight-and-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Table of contents

1. Key Insights

2. Biopsy Devices: Snapshot

3. Biopsy Devices

4. Biopsy Devices: Competitive Assessment

5. Biopsy Devices: Competitive Benchmarking: By Company

6. Biopsy Devices - Commercialization Activity

7. Biopsy Devices: Regulatory

8. Biopsy Devices: Reimbursement

9. Biopsy Devices: Market Dynamics

11. Conclusion

12. Appendix

13. Bibliography

14. DelveInsight Capabilities

15. Disclaimer

16. About DelveInsight

Get the Detailed TOC of the Biopsy Devices Pipeline report here:
https://www.delveinsight.com/report-store/biopsy-devices-pipeline-insight-and-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Contact Us:

Kritika Rehani
info@delveinsight.com
+1(919)321-6187
www.delveinsight.com

304 S. Jones Blvd #2432, Las Vegas NV 89107

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biopsy Devices Pipeline Insight and Competitive Landscape, 2022 | DelveInsight here

News-ID: 2643526 • Views:

More Releases from DelveInsight Business Research

Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibrillation Space by DelveInsight
Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals. Objective of the Case Study The
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestones, Therapies in Development, Mechanisms of Action, and Routes of Administration - By DelveInsight
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics. According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Rising Cancer Burden and Technological Advancements, states DelveInsight
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies. Biopsy devices play a crucial role in disease diagnosis by
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven by Rising Surgical Procedures, Technological Advancements, and Growing Adoption of Minimally Invasive Techniques, States DelveInsight
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide. DelveInsight's General Surgery Devices Market Report 2032 provides

All 5 Releases


More Releases for Biopsy

Liquid Biopsy Market - Unlocking Insights in Liquid: Transforming the Biopsy Lan …
Newark, New Castle, USA: The "Liquid Biopsy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Liquid Biopsy Market: https://www.growthplusreports.com/report/liquid-biopsy-market/8430 This latest report researches the industry structure, sales, revenue,
Biopsy Devices Market Overview by Breast Biopsy, Lung Biopsy, Prostate Biopsy to …
Download Free PDF Sample Papers Now at Biopsy Devices Market https://www.reportsnreports.com/contacts/requestsample.aspx?name=1159148 . Biopsy devices market report analyzes various types of biopsy devices in market and their adoption patterns. It aims at estimating market size and future growth potential of biopsy devices market for different segments such as product, guidance technique, application, end user, and region. Global biopsy devices market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East
Biopsy Device Market to Increase to US$ 2,621 Mn by 2026 | Guidance System (Ster …
Key players focussing on strategic M&A for amplified market shares Patients are increasingly preferring minimally invasive surgical procedures in order to avoid conventional surgical complications and side-effects, promoting sales of biopsy devices, leading to the growth of the biopsy devices globally. In addition to enabling the accurate diagnosis, a biopsy device assures minimal patient discomfort and trauma. This is identified to be a major factor impacting the popularity of biopsy, and
Breast Biopsy Market Report 2018: Segmentation by Product (Vacuum Assisted Biops …
Global Breast Biopsy market research report provides company profile for Hologic Inc., Leica Biosystems Nussloch GmbH (Devicor Medical Products, Inc.), C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule medical Devices LLC. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume,
Biopsy Devices Market Report 2018: Segmentation by Product (Core Needle Biopsy, …
Global Biopsy Devices market research report provides company profile for C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.) and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Bone Biopsy Market 2018 | Needle Biopsy | Open Biopsy | Bone Cancer | Bone Infec …
The Global Bone Biopsy Market is growing continuously and expected to grow at a CAGR of 5.7% from 2017 to 2023. Bone biopsy is performed to diagnose various bone disorders such as bone cancer, bone infection, osteoporosis and chronic kidney disease. Nowadays, biopsy procedure has received great importance in oncology as one of the promising methods in cancer diagnostics. The demand for needle biopsy is found to be increasing from